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heterotrimeric G protein function through 
association with G
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LIC-1, a newly described ubiquitin-related protein,
inhibited both Jurkat migration toward SDF-1
 
 
 
 and
A431 wound healing, but the closely related PLIC-2
did not. PLIC-1 prevented the SDF-1
 
 
 
–induced activation
of phospholipase C, decreased ligand-induced internalization
of SDF-1
 
 
 
 receptor CXCR4 and inhibited chemotaxis signaled
by a transfected Gi-coupled receptor. However, PLIC-1
had no effect on Gs-mediated adenylyl cyclase activation,
and inhibited only the G
 
  
 
-dependent component of
Gq-initiated  increase in [Ca
 
2
 
 
 
]
 
i
 
, which is consistent with
selective inhibition of G
 
  
 
 function. PLIC-1 colocalized
P
 
with G proteins in lamellae and pseudopods, and precipitated
G
 
  
 
 in pull downs. Interaction with G
 
  
 
 did not require
PLIC-1’s ubiquitin-like or ubiquitin-associated domains,
and proteasome inhibition had no effect on SDF-1
 
 
 
 activation
of phospholipase C, indicating that PLIC-1’s inhibition of
G
 
  
 
 did not result from effects on proteasome function.
Thus, PLIC-1 inhibits Gi signaling by direct association
with G
 
  
 
; because it also interacts with CD47, a modulator
of integrin function, it likely has a role integrating adhesion
and signaling components of cell migration.
 
Introduction
 
Chemotaxis requires signaling cross-talk between chemo-
attractant receptors and the cytoskeleton. Many chemo-
attractants are recognized by G protein–coupled receptors
(GPCRs), sharing the typical structural motif of seven
membrane-spanning helices, often signaling through pertussis
toxin (PTX)-sensitive heterotrimeric Gi proteins. Chemokine
binding to the receptor promotes the release of GDP and
binding of GTP to G
 
 
 
i, leading to the dissociation of G
 
  
 
from the heterotrimeric complex. The released G
 
  
 
 can
interact with effectors including lipases, kinases, and ion
channels required for migration (Thelen, 2001).
To migrate in response to a chemotactic signal, cells need
to modulate their adhesive properties in a regulated manner.
This involves integrin activation, which can in turn be modu-
lated by association with membrane partners such as tetra-
spannins, growth factor receptors, or CD47 (Brown, 2002).
CD47 is a ubiquitous integral membrane glycoprotein,
which is physically and functionally associated with integrins
 
 
 
v
 
 
 
3, 
 
 
 
2
 
 
 
1, 
 
 
 
IIb
 
 
 
3, and 
 
 
 
4
 
 
 
1. CD47 ligation has been
shown to activate PTX-sensitive G proteins, suggesting a
mechanism through which CD47 might regulate migration
(Brown and Frazier, 2001).
PLIC-1 and PLIC-2 are two closely related proteins
originally identified through their interaction with the cyto-
plasmic tail of CD47. Sequence analysis reveals ubiquitin-like
(Ubq) domains in the amino termini of both proteins, and a
ubiquitin-associated (Uba) domain in each carboxy terminus.
The region between the Ubq and the Uba domains contains
several Sti1 motifs (Kaye et al., 2000) of unknown function.
It is this internal region that contains CD47 binding sites.
Despite high homology between the two proteins, PLIC-1
binds more tightly to CD47 than PLIC-2, perhaps because
it has two internal repeats that interact with CD47 (Wu et
al., 1999).
A connection between PLICs and both actin cytoskeleton
and intermediate filaments suggested that PLICs may partic-
ipate in CD47 regulation of adhesion and migration (Wu et
al., 1999). Here, we have investigated the role of the PLICs
in cell migration and have found that PLIC-1, but not
PLIC-2, inhibits cell migration. Surprisingly, this regulation
occurs through effects on Gi signaling rather than directly
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on integrin function. Thus, PLIC-1 is involved in commu-
nication between integrins and GPCRs and likely is a molec-
ular component of the mechanism through which CD47
regulates cell motility and Gi signal transduction.
 
Results
 
PLIC-1, but not PLIC-2, inhibits SDF-1
 
 
 
–induced 
chemotaxis of Jurkat T cells and serum-induced 
migration of A431 epithelial cells
 
To investigate any potential role for PLIC-1 or PLIC-2 in
cell migration, we created Jurkat cell lines that stably express
PLIC-1 (JPLIC-1), PLIC-2 (JPLIC-2), or a neomycin resis-
tance gene alone (JC). We studied SDF-1
 
 
 
–induced che-
motaxis of these cell lines, using a transwell assay. As shown
in Fig. 1 A, JPLIC-1 migrated more poorly than JC, whereas
JPLIC-2 did not show any significant decrease in migration.
The difference in effect on migration was true for multiple
independently derived clones of both PLIC-1 and PLIC-2
expressors. Expression level of the SDF-1
 
 
 
 receptor CXCR4
was comparable for all cell lines (not depicted), and expres-
sion levels of transfected PLIC-1 and PLIC-2 also were com-
parable (Fig. 1 A, inset). Thus, PLIC-1, but not PLIC-2, in-
hibited SDF-1
 
 
 
–induced chemotaxis of Jurkat T cells. As
expected, because CXCR4 is a Gi-coupled receptor (Chen et
al., 1998), PTX completely inhibited Jurkat migration in re-
sponse to SDF-1
 
 
 
 (Fig. 1 C).
To evaluate whether PLIC-1 inhibition of migration also
occurred in another cell type, we performed an in vitro
wound healing assay on A431 epithelial cells stably trans-
fected with empty vector, PLIC-1 or PLIC-2 (Wu et al.,
1999). As shown in Fig. 1 B, PLIC-1, but not PLIC-2,
transfectants migrated less than the controls. Thus, PLIC-1
also inhibited migration of A431 epithelial cells, although to
a lesser extent than its inhibition of Jurkat migration to
SDF-1
 
 
 
. Because the SDF-1
 
 
 
 receptor CXCR4 signals ex-
clusively through a PTX-sensitive Gi heterotrimer, we rea-
soned that the smaller effect of PLIC-1 on A431 migration
might result from recruitment of Gi-independent mecha-
nisms for stimulating migration in the wound healing assay,
perhaps from growth factors in the cell culture medium.
PTX pretreatment partially inhibited migration of A431
cells into the wound (Fig. 1 C), indicating that migration of
A431 cells in this assay is only partly dependent on Gi sig-
naling. This suggests that PLIC-1 affects Gi-dependent cell
migration, but not cell migration initiated by other path-
ways.
 
PLIC-1 blocks SDF-1
 
 
 
–induced PLC
 
 
 
 activation
 
To test whether PLIC-1 directly affected Gi signaling, we as-
sessed the ability of PLIC-1 to alter [Ca
 
2
 
 
 
]
 
i
 
 responses. As
shown in Fig. 2 A, whereas SDF-1
 
 
 
 induced an increase in
[Ca
 
2
 
 
 
]
 
i
 
 in both JC and JPLIC-2, JPLIC-1 was unable to
mount any increase in [Ca
 
2
 
 
 
]
 
i
 
 in response to this agonist.
This difference between the effects of PLIC-1 and PLIC-2
on SDF-1
 
 
 
–induced calcium also was reproduced in inde-
pendently derived clones. PTX completely blocked SDF-
1
 
 
 
–induced [Ca
 
2
 
 
 
]
 
i
 
 in JC, confirming its dependence on Gi
signaling (unpublished data). In contrast, PLIC-1 had no
significant effect on the [Ca
 
2
 
 
 
]
 
i
 
 increase induced by cross-
linking the T cell antigen receptor (Fig. 2 C), which is de-
pendent on tyrosine kinase rather than heterotrimeric G
protein signaling (Mustelin and Tasken, 2003).
Because calcium release from intracellular stores in re-
sponse to heterotrimeric G protein activation is a conse-
quence of IP3 generation by PLC
 
 
 
 (Rhee, 2001), we mea-
sured intracellular levels of IP3 after SDF-1
 
 
 
 addition in
both JC and JPLIC-1. As shown in Fig. 2 B, IP3 increased
30 s after SDF-1
 
 
 
 addition to JC, but remained at baseline
in JPLIC-1. Because PLC
 
 
 
2 is a direct effector of G
 
  
 
(Rhee, 2001), we verified that PLIC-1 inhibition was not
due to alterations in expression of either G
 
 
 
 or PLC
 
 
 
2
protein in JPLIC-1 (Fig. 2 D). Thus, PLIC-1 expression
Figure 1.  PLIC-1 but not PLIC-2, inhibits Gi-dependent migration 
of Jurkat T cells and A431 epithelial cells. (A) Jurkat T cells trans-
fected with PLIC-1 (JPLIC-1), PLIC-2 (JPLIC-2), or empty vector (JC) 
were loaded in the upper chamber of a transwell and allowed to 
migrate to the lower chamber containing SDF-1 . 5 h later, cells 
that had migrated through the filters into the lower compartment 
were counted. Samples were performed in triplicate. Results indicate 
migration relative to the controls (100%) and represent the mean 
of at least three experiments   SEM; the asterisk indicates P   0.05 
between control cells and PLIC-1 transfectants. (Inset) Protein 
expression of myc-tagged PLIC-1 or PLIC-2 shown over the relevant 
bar was assessed by anti-myc Western blot in total cell lysates from 
JPLIC-1 or JPLIC-2. PLIC-2 is  5 kD larger than PLIC-1. (B) A confluent 
monolayer of A431 epithelial cells transfected with PLIC-1, PLIC-2, 
or empty vector was wounded. The distance between wound edges 
was measured with a micrometer at initiation of wounding and 5 h 
later, and the distance covered by migrating cells was calculated. 
Results are expressed as percentage of wound closure relative to 
vector-transfected controls, and represent the mean of three 
experiments   SEM; the asterisks indicate P  0.05. (Inset) Protein 
expression of PLIC-1 and PLIC-2 in the transfectants was assessed as 
described above. (C) Before the migration assays described in A and 
B, control cells were pretreated with PTX. Results represents three 
independent determinations   SEM; the asterisks indicate P   0.05. 
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blocked SDF-1
 
 
 
–induced PLC
 
 
 
 activation. Because PLC
activation by CXCR4 was completely inhibited by PTX,
and the G
 
 
 
i subunit does not interact with PLC
 
 
 
 (Rebecchi
and Pentyala, 2000), these data demonstrate that PLIC-1 in-
terferes with G
 
  
 
 activation of PLC
 
 
 
2.
To determine whether PLC
 
 
 
-mediated increase in [Ca
 
2
 
 
 
]
 
i
 
was required for migration of Jurkat or A431, we examined
migration in cells treated with the intracellular Ca
 
2
 
 
 
 chelator
BAPTA or with the PLC inhibitor U73122. Both BAPTA
and U73122 prevented chemotaxis, suggesting a role for
PLC in migration of these cells (Fig. 2 E). Thus, PLIC-1 in-
hibition of SDF-1
 
 
 
–induced PLC
 
 
 
 activation likely con-
tributes to its inhibition of migration.
 
PLIC-1 inhibits Gi- and Gq-, but not Gs-coupled signaling
 
To determine whether PLIC-1 affected migration mediated
through Gi-coupled receptors other than CXCR4, JPLIC-1,
JPLIC-2, and JC were transiently transfected with the
Gi-coupled receptor activated solely by a synthetic ligand
(RASSL) Ro2, which is similar to 
 
 
 
-opioid receptors but
binds spiradoline rather than an opioid ligand (Coward et
al., 1998). JC and JPLIC-2 transfected with this receptor
migrated in response to spiradoline, but JPLIC-1 cells did
not (Fig. 3 A), despite equal expression of the transfected
RASSL (not depicted). Thus, PLIC-1 inhibits migration
through two different Gi-coupled receptors in Jurkat cells.
To determine the specificity of the inhibitory effect of
PLIC-1 for Gi signaling, JPLIC-1, JPLIC-2, and JC were
transfected with the Gs-coupled 
 
 
 
2 adrenergic receptor or
the Gq-coupled M3 muscarinic receptor. Gs signaling was
determined by measurement of cAMP production after ad-
dition of isoproterenol. PLIC-1 had no effect on the Gs-
mediated cAMP increase (Fig. 3 B). Gq function was as-
sessed by increase in [Ca
 
2
 
 
 
]
 
i
 
 after addition of carbachol;
JPLIC-1 showed about half the response of JC or JPLIC-2
(Fig. 3 C). Because Gq-coupled receptors can activate PLC
 
 
 
through both G
 
 
 
q (which activates primarily PLC
 
 
 
1) and
Figure 2.  PLIC-1 inhibits PLC activation in response to SDF-1 , 
but not after CD3 ligation. (A) Fura-2–loaded JC, JPLIC-1, or JPLIC-2 
were stimulated with SDF-1 . Intracytoplasmic calcium concentration 
was determined from fluorescence ratios. A representative experi-
ment of three is shown. (B) JC or JPLIC-1 cells were stimulated with 
SDF-1  for the indicated times and the amount of IP3 was determined 
using a radioreceptor assay. A representative experiment of three   
SEM is shown. (C) Fura-2–loaded JC or JPLIC-1 were labeled with 
anti-CD3 antibody before addition of goat anti–mouse secondary 
antibody for cross-linking (arrow). A representative experiment of 
three is shown. (D) Protein expression level of PLC 2 and G  in JC 
and JPLIC-1 cell lysates was assessed by Western blot using rabbit 
polyclonal antibodies. (E) Before migration assays, untransfected 
Jurkat or A431 epithelial cells were pretreated with the calcium 
chelator BAPTA or the PLC inhibitor U73122. Cell migration was 
assessed as in Fig. 1. This graph represents the mean of three 
independent determinations   SEM; the asterisks indicate P   0.05.
Figure 3. PLIC-1 inhibits Gi and Gq, but not Gs signaling. 
JC, JPLIC-1, and JPLIC-2 cells were transiently transfected with Gi-, 
Gs-, or Gq-coupled GPCRs and tested for related functions. (A) Cells 
expressing the Gi-coupled receptor Ro2 were loaded in the upper 
chamber of a transwell apparatus and tested for migration in 
response to spiradoline. Migrating cells recovered from the bottom 
chamber were counted and migration of JPLIC-1 and JPLIC-2 cells 
expressed relative to JC (100%). This graph represents the mean   
SEM of three independent experiments; the asterisk indicates P   0.05. 
(B) Isoproterenol-induced cAMP production was measured in JC, 
JPLIC-1, and JPLIC-2 cells transiently expressing the  2 adrenergic 
receptor. Data represent the mean   SEM of three independent 
experiments. (C) Changes in [Ca
2 ]i in response to carbachol were 
measured in cells transfected with the M3 muscarinic receptor 
alone or with Pd-like protein. Net calcium increase in JC cells was 
normalized to 100%, and increase from JPLIC-1 and JPLIC-2 cells 
determined relative to JC. This graph represents the mean   SEM of 
at least five independent experiments; the asterisks indicate P   0.05. 
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G
 
  
 
 (which activates primarily PLC
 
 
 
2; Rhee, 2001), these
data suggested the possibility that PLIC-1 interfered only
with G
 
  
 
-dependent component of Gq-mediated calcium
increase. To test this hypothesis, the G
 
  
 
 inhibitor phosdu-
cin (Pd)-like protein (PhLP; Thibault et al., 1997; Mc-
Laughlin et al., 2002) was cotransfected with the M3 musca-
rinic receptor into JC or JPLIC-1 cells. PhLP expression
partially decreased the calcium response in JC cells, to a
comparable extent as PLIC-1 (Fig. 3 C). In contrast, expres-
sion of PhLP induced no additional decrease in JPLIC-1
cells (Fig. 3 C) despite equal expression of the transfected
protein (not depicted), demonstrating that PLIC-1 and
PhLP act on the same pathway of Gq signal transduction.
To determine if other G   functions were inhibited by
PLIC-1, we tested CXCR4 endocytosis after addition of
SDF-1 , because release and activation of G   from the
heterotrimeric G protein is required for GRK-mediated in-
ternalization of GPCRs (Penn et al., 2000). As shown in Fig.
4, endocytosis of CXCR4 after SDF-1  addition was de-
creased in JPLIC-1 compared with JC or JPLIC-2.
PLIC-1 colocalizes with G proteins and directly 
interacts with G  
Because PLIC-1 interfered with G  -dependent func-
tions, we looked for a possible association between these
Figure 4. PLIC-1 blocks SDF-1 –induced CXCR4 endocytosis. 
JC, JPLIC-1, or JPLIC-2 cells were stimulated with SDF-1  for 0 or 
5 min. At each time point, cells were washed and labeled with a 
CXCR4 antibody and surface expression determined by cytofluorimetry. 
A representative experiment   SEM is shown.
Figure 5. PLIC-1, not PLIC-2, colocalizes with 
G . Murine lung fibroblasts plated on glass cover-
slips were transfected with myc-tagged (A) PLIC-1 
or (B) PLIC-2 and maintained in complete medium 
for 24 h. Cells were fixed in formaldehyde and 
stained for both myc tag (green) and endogenous 
G  (red).PLIC-1 inhibits G   function | N’Diaye and Brown 1161
proteins. Immunofluorescence studies were done in fibro-
blasts because Jurkat cell round morphology interfered
with attempts to see specific localization of the proteins.
Cells transfected with myc-tagged PLIC-1 or PLIC-2, and
stained for both myc and endogenous G  showed partial
colocalization of PLIC-1 with G  at lamella borders and
other sites of membrane protrusions (Fig. 5 A). In con-
trast to PLIC-1, PLIC-2 staining revealed a cytosolic
punctate pattern that did not colocalize with G  (Fig. 5
B). Thus, a subset of PLIC-1 but not of PLIC-2 colocal-
ized with G .
To examine potential association directly, in vitro pull-
down assays using GST–PLIC-1 were performed. PLIC-1
specifically bound G  from membranes of Jurkat cells (Fig.
6 A), A431 and HEK-293 cells (not depicted). GST alone
and GST–syntaxin 2 did not bind G  from any of these
cells, and GST–PLIC-1 did not bind lck, which, like G  ,
is anchored to the plasma membrane by a lipid modifica-
tion (unpublished data). Unlike G , G i did not specifi-
cally associate with GST–PLIC-1 even after addition of 100
 M GTP– -S to the cell lysate (not depicted), nor did
PLC 2 (Fig. 6 A) or either of the other PLC  isoforms ex-
pressed in Jurkat cells (not depicted). To determine the do-
main(s) of PLIC-1 required for binding to G , deletion
mutants of PLIC-1 were made as shown in Fig. 6 B. Dele-
tion of both the amino-terminal Ubq and the carboxy-ter-
minal Uba domains did not decrease G  binding, demon-
strating that the central domain of PLIC-1, which contains
the Sti1 motifs, is sufficient for this interaction. Purified
G   bound to the same PLIC-1 domain, demonstrating
that the interaction is direct (Fig. 6 C). Thus, PLIC-1 binds
G  , and the primary site of association is likely to be at
membrane protrusions where PLIC-1 preferentially local-
izes to the plasma membrane.
PLIC-1 inhibition of G protein signaling is independent 
of effects on proteasome activity
Previous papers have reported the ability of the carboxy-ter-
minal Uba domains of PLIC-related proteins to bind ubiq-
uitinated proteins (Funakoshi et al., 1999; Kleijnen et al.,
2000; Mah et al., 2000; Bedford et al., 2001). PLIC family
members also bind ubiquitin ligases and proteasome sub-
units via their amino-terminal Ubq domain (Kleijnen et al.,
2000). These interactions are thought to interfere with nor-
mal targeting of proteins for proteasome-dependent degra-
dation, resulting in enhanced stability, potentially affecting
signaling pathways in which these proteins are involved.
However, steady-state levels of G  and PLC 2 were unaf-
fected by PLIC-1 transfection (Fig. 2 D), demonstrating
that PLIC-1 inhibition of signaling was not dependent on
alteration of the concentration of proximal and distal effec-
tors of the signaling pathway.
To test the possibility that PLIC-1 could affect G   func-
tions by interfering with proteasome activity, we examined
the effects of the proteasome inhibitor lactacystin on [Ca
2 ]i
increase in response to SDF-1 . Lactacystin, which induced
a significant accumulation of ubiquitinated proteins in the
cells (inset), did not significantly affect SDF-induced cal-
cium changes (Fig. 7). Therefore, we conclude that PLIC-1’s
inhibition of G   signaling does not require any effect it
may have on proteasome activity.
Discussion
The PLICs are a newly recognized family of cytoplasmic and
nuclear proteins that have been implicated in a wide variety
Figure 6. PLIC-1 directly binds G . (A) GST, GST–PLIC-1, or GST–
syntaxin2 were incubated with solubilized membranes from Jurkat 
cells (input). The material from cell lysates that bound to each column 
was run on SDS-PAGE gel and probed with antibodies against G , 
G i, or PLC 2. In the right lane, 10% of the starting membrane 
lysate was analyzed. (B) Full-length PLIC-1 and various deletion 
mutants were fused to GST and used in the pull-down assay. GST 
alone (1), full-length PLIC-1 (2), PLIC 1 [aa534–582] (3), PLIC-1 
[aa1–538] (4), and PLIC1 [aa100–533] (5) are schematically depicted 
above the Western blot of material retained by each column and 
probed for G . (C) Full-length PLIC-1 and the deletion mutants 
described in B were incubated with purified G  , and material 
retained by each column probed for G  as in B.
Figure 7.  Proteasome inhibition does not block SDF-1 –induced 
increase in [Ca
2 ]i. Lactacystin-treated Jurkat cells were loaded with 
Fura-2, stimulated with SDF-1  and changes in intracellular calcium 
recorded. A representative experiment is shown. To assess lactacystin-
induced inhibition of the proteasome activity, lysates from vehicle- 
or lactacystin-treated cells ( LC) were run on SDS-PAGE gel and 
probed for ubiquitinated proteins with an antiubiquitin Western 
blot (inset). 1162 The Journal of Cell Biology | Volume 163, Number 5, 2003
of cellular functions, ranging from inhibition of the cell cy-
cle to stabilization of plasma membrane proteins, and to re-
arrangements of cytoskeleton (Biggins et al., 1996; Funako-
shi et al., 1999; Wu et al., 1999; Bedford et al., 2001).
There are four PLIC family members in the mouse and hu-
man genomes, and the family is conserved through evolu-
tion to the Saccharomyces cerevisiae protein dsk2 (Fig. 8). All
members of the family have amino-terminal Ubq and car-
boxy-terminal Uba domains, and the intervening sequences
in all metazoan PLICs contain two internal repeats of  85
aa that contain Sti1 motifs (Kaye et al., 2000). Through
yeast two-hybrid approaches, various PLICs have been
shown to bind membrane proteins including presenilins,
GABA receptors, and CD47; signaling molecules including
mTOR (Wu et al., 2002) and cyclin A (Funakoshi et al.,
1999); and the chaperonin Stch (Kaye et al., 2000). In addi-
tion, both nuclear and cytoplasmic localizations have been
reported for different members of the family (Funakoshi et
al., 1999; Kleijnen et al., 2000). The Ubq domains of PLIC-2
(Kleijnen et al., 2000; Walters et al., 2002) and of the
yeast dsk2 (Funakoshi et al., 2002), bind to components of
the proteasome, whereas the Uba domains bind to a variety
of ubiquitinated proteins (Kleijnen et al., 2000). Thus, at
least some members of the family may be involved in target-
ing ubiquitinated proteins to the proteasome. However,
transfection of PLICs generally inhibits ubiquitin-depen-
dent proteasome degradation (Kleijnen et al., 2000), sug-
gesting that its normal function in protein turnover may be
inhibited by overexpression. Although this could explain
why expression of the Xenopus homologue of human A1u
and mouse Ubin, called XDRP-1, could interrupt cell cycle
by preventing ubiquitin-mediated degradation of cyclin A
(Funakoshi et al., 1999), it would not explain why direct
binding of PLIC-1 and its human homologue to several
membrane proteins would stabilize these proteins at their
membrane location (Mah et al., 2000; Bedford et al., 2001).
Some of this perplexing multitude of functions of the
PLICs may derive from the fact that the four isoforms in hu-
man and mouse have different functions and different local-
izations in the cell. However, to date, differences in function
or localization among the PLICs have not been reported and
only minimally investigated. PLIC-1 and PLIC-2 are the
most closely related family members (Fig. 8), yet our data
show that they have very different roles in regulating GPCR
signaling and very distinct subcellular localizations. PLIC-1,
but not PLIC-2, inhibits migration of both A431 epithelial
cells and Jurkat T cells. Although we had expected that this
would be because of the effects of PLIC-1 on cytoskeleton
(Wu et al., 1999), our data suggest that a direct and unique
effect of PLIC-1 is on GPCR signaling. Specifically, our
data support the hypothesis that PLIC-1 binds the G  
subunit of heterotrimeric G proteins and interferes with its
normal functions. PLIC-1 precipitated G   in pull-down
assays and blocked G  -dependent PLC activation that
normally results from SDF-1  binding to CXCR4. Further-
more, PLIC-1 inhibited CXCR4 internalization, which de-
pends on G   release from the G protein after ligand bind-
ing to the receptor. In contrast, PLIC-1 did not affect G s
effector function and likely did not interfere with G q func-
tion either, suggesting that its effects are specific for G  .
Unfortunately, we were unable to test G i function directly
because G i does not decrease cAMP in leukocytes (del
Pozo et al., 1995; Elferink and VanUffelen, 1996). How-
ever, we did not find evidence for PLIC-1 association with
G i even under conditions where Gi was activated by
GTP S. In each case, PLIC-2 did not have these functional
effects, and, unlike PLIC-1, never localized to plasma mem-
brane, clearly distinguishing the roles for these two closely
related proteins. It is of interest that PLIC-2 can associate
with membranes in simple fractionation experiments (Wu et
al., 1999), suggesting that it may have some role in regula-
tion of signaling at an intracellular membrane or that the cy-
tosolic aggregates in which it can be found (Fig. 5) may be
associated with membranes.
We considered several alternative possibilities for the
mechanism by which PLIC-1 affected CXCR4 signaling and
cell migration. First, we considered that it might affect Ca
2 
release from cytoplasmic stores in general. However, release
of Ca
2  by ligation of CD3 was normal, demonstrating that
activation of PLC  and subsequent release of Ca
2  stores
was unaffected by PLIC-1. We considered that as a protein
potentially involved in proteasome function, PLIC-1 might
affect the concentration of one or more of the proteins in-
volved in signaling to PLC ; however, CXCR4 itself, G  ,
and PLC 2 expression all were unaffected by PLIC-1. Fur-
thermore, SDF-1  binding to CXCR4 was unaffected by
PLIC-1 expression. Finally, we considered that PLIC-1 inhi-
bition of proteasome activity might lead to the signaling
aberrations. This is unlikely for several reasons: first, lacta-
cystin, which clearly inhibited proteasome function, had
Figure 8.  The PLIC family of proteins. A phylogenetic tree of multiple 
members of the PLIC family is depicted. Alignments were performed 
using ClustalW (31) at the European Bioinformatics Institute web 
site (http://www.ebi.ac.uk/clustalw) and displayed using TreeView 
(32). The protein GenBank/EMBL/DDBJ accession numbers are: 
NP 608344.1 (Drosophila); AAF 01366 (Mus PLIC-2); AAG 02474 
(Homo Ubq-2); AAF01365 (Mus PLIC-1); BAA92267 (Rat DA41); 
AAG02473 (Homo Ubq-1); AAK61367 (Bos retina); BAA82642.1 
(XDRP1); AAF80171 (Homo A1u); BAB40326 (Mus Ubin); NP 
491996.1 (C. elegans); NP 179311.1 (Arabidopsis); AAF43003.1 
(Dictyostelium); NP 014003.1 (S. cerevisiae dsk2); NP 594159.1 
(S. pombe); AAF67143 (Homo Ubq-3); and BAC36593.1 (Mus 
PLIC-3). The PLIC proteins are also called ubiquilins (Ubq). By this 
nomenclature, human A1u and its mouse orthologue Ubin should 
be PLIC-4 or ubiquilin-4.PLIC-1 inhibits G   function | N’Diaye and Brown 1163
minimal effect on CXCR4-mediated cytoplasmic Ca
2  rise;
second, to the extent that it has been studied, PLIC-2 is
equivalent to PLIC-1 for proteasome inhibition (Kleijnen et
al., 2000); and, finally, we saw no detectable accumulation
of ubiquitinated proteins in the PLIC-1 transfectants. Fur-
thermore, although ubiquitination of CXCR4 leads to its
degradation, endocytosis of this receptor is independent of
its ubiquitination (Marchese and Benovic, 2001), suggesting
the effect of PLIC-1 on its internalization is not ubiquitin
dependent. Thus, the data are most consistent with PLIC-
1–mediated inhibition of G   function independent of its
ability to interfere with proteasome activity, and likely
through its binding to G  . PLIC-1 has functional similari-
ties with the Pd family of G protein signaling regulators
(Schulz, 2001). Pd and its homologue PhLP both bind G  
directly with high affinity and inhibit G  -dependent func-
tions by sequestration. Pd, by binding to G  , inhibits
 2-adrenergic receptor kinase translocation to the plasma
membrane and internalization of the receptor; PhLP blocks
internalization of the  -opioid receptor (Schulz, 2001). Al-
though Pd is expressed exclusively in the retina, PhLP has a
broad distribution, and we have found it in Jurkat cells (un-
published data).
Inhibition of G   function is sufficient to account for the
ability of PLIC-1 to block cell migration, without postulat-
ing additional effects on integrin or cytoskeletal function.
Previous papers by the Bourne and Charo groups have estab-
lished that Gi-mediated chemotaxis absolutely requires re-
lease of G   from G i, with subsequent activation of G  
effectors (Arai et al., 1997; Neptune and Bourne, 1997). Al-
though deletion of the PLC 2 gene in mice caused primary
PMN and lymphocytes to migrate faster (Jiang et al., 1997),
in our system, both Ca
2  clamping and a PLC inhibitor dra-
matically decreased cell migration, to about the same extent
as PTX. Although reasons for the difference between our re-
sults and the knockout are unknown, the fact that there is
PTX-sensitive migration in PLC 2 /  cells suggests that
there may be other G  -dependent effector mechanisms
important in migration that also are affected by PLIC-1.
These data are the first to demonstrate a significant bio-
logical difference between members of the PLIC family. We
suggest that the difference in function results, at least in part,
from the difference in subcellular localization of PLIC-1
and PLIC-2. Based on what is known of function so far, it
appears that PLIC-1 is most closely associated with plasma
membrane, PLIC-2 with cytosolic proteasomes, and A1u
(called Ubin in the mouse) is likely predominantly expressed
in the nucleus. Its ability to associate with the plasma mem-
brane likely is necessary for PLIC-1 to prolong the half-life
of GABA receptors and presenilins. It is intriguing that the
three membrane proteins (including CD47) with which
PLIC-1 has been associated all span the membrane multiple
times. It may be that this architecture is important for
PLIC-1 interaction.
Finally, it is tantalizing that CD47 is a plasma membrane
binding site for PLIC-1 because CD47 ligation has been as-
sociated with a nonclassical mechanism for Gi activation
(Brown and Frazier, 2001). It may be that CD47 ligation re-
sults in loss of association with PLIC-1, releasing an inhibi-
tion of Gi signaling, or it may be that activation of Gi signal-
ing through another mechanism recruits PLIC-1 to CD47
at the plasma membrane to restore homeostasis. In either
case, the interaction of PLIC-1 with CD47 may represent a
novel mechanism for regulation of G protein signaling, and
understanding the mechanisms involved in regulating the
interaction of these two proteins is likely to reveal additional
potential pathways for control of this major plasma mem-
brane signaling pathway.
Materials and methods
Cell culture and transfection
Jurkat cells (E6 clone) were cultured in RPMI 1640 supplemented with
10% FCS, 2 mM glutamine, and 0.1% gentamycin. Stably transfected Jur-
kat cells were maintained under selection with 1.5 mg/ml geneticin (Life
Technologies; Reinhold et al., 1997, 1999; Rebres et al., 2001a). A431 ep-
ithelial cells and 3656 fibroblasts were maintained in Dulbecco’s mini-
mum Essential medium with 10% FCS. A431 stable transfectants were se-
lected with 400  g/ml geneticin (Wu et al., 1999).
cDNA constructs
cDNA encoding myc or GST-tagged PLIC1 or PLIC-2 were described pre-
viously (Wu et al., 1999). GST–syntaxin 2 cDNA was a gift from K. Mostov
(University of California San Francisco, San Francisco, CA [UCSF]). HA-
tagged M3 muscarinic receptor and Flag-tagged  2 adrenergic receptor
cDNAs were provided by H. Bourne (UCSF; Neptune and Bourne, 1997).
The cDNA encoding the RASSL Ro2 (Coward et al., 1998) was a gift of B.
Conklin (UCSF). Pd-like protein construct was provided by B. Willardson
(Brigham Young University, Provo, UT).
To generate deletion mutants of PLIC-1 in fusion with GST, PCR prod-
ucts encompassing the coding regions of PLIC-1 (1–538), PLIC-1 (534–
582), and PLIC-1 (100–533) were cloned in frame with the coding region
of GST in pGEX-KG vector. The different domains were generated by PCR
using the following primers: PLIC-1 (534–582): 5 -GCGAATTCCGCA-
GAGTCCAGAAGTCAGATT-3  and 5 -TGCACTCGAGCTATGACGGC-
TGGGAACCCAGC-3 ; PLIC-1 (1–538): 5 -TGACGGAATTCTTGCCATG-
GCCGAGAGCGCAGAGAGCG-3  and 5 -TCGGCCCTCGAGCTATC-
AGACTTCTGGACTCTGCAGCTGAGGGTT-3 ; PLIC-1 (100–533): 5 -
CAGGCGGAATTCGACCGCAAGATAATTCAGCTCAGCAAACA-3  and
5 -TCGGCCCTCGAGCTATCAGACTTCTGGACTCTGCAGCTGAGGGTT-3 .
The PCR products were digested with EcoRI/XhoI and cloned into pGEX-
KG, and subsequently sequenced to verify that no errors had been intro-
duced during PCR or cloning.
mAbs and reagents
SDF-1  was from PeproTech. Purified G  , PTX, U-73122, BAPTA-AM,
lactacystin, GTP– -S, isoproterenol, and carbachol were purchased from
Calbiochem. Spiradoline was purchased from Sigma-Aldrich. Fura-2–AM
was purchased from Molecular Probes. The anti-CD3 mAb (OKT3) was
purchased from American Type Culture Collection. G  antibodies were
purchased from Upstate Biotechnology or BD Transduction Laboratories.
Anti-myc antibodies were purchased from Upstate Biotechnology or Invi-
trogen. Lck, PLC 2, and G i antibodies were purchased from Santa-Cruz
Biotechnology, Inc. IP3 and cAMP assay kits were purchased from Amer-
sham Biosciences and BIOMOL Research Laboratories, Inc., respectively.
Cell migration
Chemotaxis of Jurkat T cells in response to SDF-1  was determined using a
24-well plate with 3- m-pore inserts (BD Biosciences). After filling the
lower chamber with medium alone or medium containing 500 ng/ml SDF-
1 , 4   10
5 Jurkat T cells (2   10
6/ml in RPMI 1640, 1% FCS) were loaded
in the upper chamber. Plates were incubated for 3 h at 37 C in a humidi-
fied atmosphere containing 5% CO2, and cell migration assessed by count-
ing cells in the lower chamber on a hemocytometer. Each experiment was
performed in triplicate. The same procedure was used to assess migration
of Ro2-transfected Jurkat cells in response to 1  M spiradoline.
To assess wound healing, A431 cells transfected with empty vector,
PLIC-1, or PLIC-2 were grown to confluency. The monolayers were
wounded with a pipette tip, washed, and the distance between wound
edges measured using a micrometer at specifically marked points along
the wound. After 5 h at 37 C in a humidified atmosphere containing
5% CO2, the distance between wound edges was measured again at the
same sites, and the distance covered by migrated cells determined. At least1164 The Journal of Cell Biology | Volume 163, Number 5, 2003
three different points were used to determine the average distance mi-
grated along the wound edge. In some experiments, confluent monolayers
were pretreated overnight with 100 ng/ml PTX, or for 30 min with 4  M
U73122 or 25  M BAPTA before wounding.
Intracellular calcium measurement
Jurkat T cells (2   10
7 cells/ml) in growth medium were loaded with Fura-2
as described previously (Rebres et al., 2001a,b). Cells were washed once
with complete medium and twice with ice-cold Ca
2  buffer (25 mM
Hepes, pH 7.4, 125 mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 1 mM CaCl2,
0.5 mM MgCl2, 0.1% BSA, and 0.1% glucose), resuspended at 3   10
6
cells/ml in Ca
2  buffer, and kept on ice until use. Before stimulation, cells
were transferred into cuvettes, prewarmed to 37 C, and placed in a spec-
trofluorimeter (model F-4500; Hitachi Instruments) after which SDF-1 
was added to the stirred cell suspension to a final concentration of 2  g/
ml. To assess the Ca
2  response to TCR cross-linking, cells were incubated
with OKT3 (American Type Culture Collection) for 30 min on ice, washed
twice, and 10  g/ml anti–mouse IgG was added to the cuvette to cross-link
bound antibody in place of SDF-1 . In Jurkat cells transfected with the M3
muscarinic receptor, changes in [Ca
2 ]i were measured after stimulation
with 100  M carbachol. Fluorescence was monitored as described previ-
ously (Green et al., 1997) and [Ca
2 ]i was calculated by the method of
Grynkiewicz et al. (1985).
Measurement of intracellular IP3 level
Intracellular IP3 concentration was determined using a radioreceptor assay
(Amersham Biosciences). Jurkat T cells were stimulated with 2  g/ml SDF-
1  for various times, and the reaction ended by addition of 0.2 vol ice-
cold 20% perchloric acid. The samples were handled, IP3 was measured,
and IP3 concentration was calculated exactly as per the manufacturer’s in-
structions.
Measurement of CXCR4 endocytosis
Vector or PLIC-1 transfected Jurkat cells were stimulated with 500 ng/ml
SDF-1  for 0 or 5 min. At end point, cells were chilled, washed with cold
PBS, and incubated with 10  g/ml a CXCR4 antibody (Prosciences) for 30
min at 4 C, and subsequently with Alexa 488–coupled anti–mouse IgG
(Molecular Probes). Cells were fixed and fluorescence of individual cells
was measured by flow cytometry (Coulter Epics).
Immunostaining of PLICs and G 
Murine 3656 fibroblasts plated onto coverslips were transfected with myc-
tagged PLIC-1 or PLIC-2 and maintained in complete medium for 24 h.
Cells were fixed with 3.7% PFA, briefly permeabilized with 0.1% Triton
X-100, and stained with Alexa 488–labeled anti-myc (clone 9E10; Upstate
Biotechnology) and Alexa 594–labeled anti-G  (BD Transduction Labora-
tories).
Image acquisition
Images shown in Fig. 5 were acquired using a microscope (Axiovert
100TV; Carl Zeiss MicroImaging, Inc.), with a Plan-APOCHROMAT 63X
inverted oil objective lens with an NA of 1.40. Cells were fixed and stained
with specific antibodies coupled to Alexa 488 or Alexa 594 as described in
Immunostaining of PLICs and G , and mounted in Prolong medium (Mo-
lecular Probes). Images were acquired with a CCD camera (Micromax;
Princeton Instruments) using IPLabs software and subsequently merged us-
ing Adobe Photoshop.
GST pull down
GST–PLIC-1 and controls were induced by addition of 0.1 mM IPTG (16 h/RT)
to bacterial cultures. Lysates were incubated with GSH-agarose beads
(Amersham Biosciences) overnight at 4 C. The beads were washed with a
buffer containing 20 mM Hepes, pH 7.4, 25 mM NaCl, 0.5% Triton X-100,
10% glycerol, 0.1%  ME, and extensively washed with 20 mM Hepes, pH
7, 150 mM KCl. Cell membranes were prepared by centrifugation of soni-
cated cells at 100,000 g for 1 h and solubilized in 0.1% Triton X-100 for
2 h at 4 C under constant rotation. Solubilized proteins were separated
from insoluble pellet by centrifugation at 15,000 g, and incubated with the
GST protein–loaded agarose beads overnight at 4 C. After washing, bead-
bound protein was eluted in Laemmli buffer and analyzed by SDS-PAGE
and Western blot. To assess potential G i binding, the membrane lysate
was incubated with 100  M GTP– -S for 15 min at 30 C before incuba-
tion with fusion proteins.
To test direct binding of G  , 12 ng of purified G   (Calbiochem) was
incubated with the same amount of GST fusion proteins in PBS/0.1% Tri-
ton X-100 overnight at 4 C. Bead pellets were washed three times, solubi-
lized in Laemmli buffer and analyzed by SDS-PAGE and Western blot.
Statistical analysis
Data were analyzed by t test.
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